User profiles for Irene Vanni

Irene Vanni

Università di Firenze
Verified email at unifi.it
Cited by 51

[HTML][HTML] Current state of target treatment in BRAF mutated melanoma

ET Tanda, I Vanni, A Boutros, V Andreotti… - Frontiers in molecular …, 2020 - frontiersin.org
Incidence of melanoma has been constantly growing during the last decades. Although
most of the new diagnoses are represented by thin melanomas, the number of melanoma-…

Exosomes: a new horizon in lung cancer

I Vanni, A Alama, F Grossi, MG Dal Bello, S Coco - Drug discovery today, 2017 - Elsevier
Highlights • Exosomes play a key part in tumorigenesis and progression of cancer. • Exosomes
can be isolated from cell culture media and almost all body fluids. • Exosomes are cargos …

The energy distribution of the first supernovae

…, Á Skúladóttir, M Rossi, I Vanni… - Monthly Notices of …, 2023 - academic.oup.com
The nature of the first Pop III stars is still a mystery and the energy distribution of the first
supernovae is completely unexplored. For the first time we account simultaneously for the …

[HTML][HTML] The current state of molecular testing in the BRAF-mutated melanoma landscape

I Vanni, ET Tanda, F Spagnolo, V Andreotti… - Frontiers in Molecular …, 2020 - frontiersin.org
The incidence of melanoma, among the most lethal cancers, is widespread and increasing.
Metastatic melanoma has a poor prognosis, representing about 90% of skin cancer mortality. …

[HTML][HTML] Association between response to nivolumab treatment and peripheral blood lymphocyte subsets in patients with non-small cell lung cancer

…, A Alama, S Coco, S Boccardo, I Vanni… - Frontiers in …, 2020 - frontiersin.org
Immune checkpoint blockade represents a major breakthrough in advanced non-small cell
lung cancer (NSCLC) therapy. However, success is limited to a subset of patients and there is …

[HTML][HTML] Clinical applications of circulating tumor cells in lung cancer patients by CellSearch system

A Truini, A Alama, MG Dal Bello, S Coco, I Vanni… - Frontiers in …, 2014 - frontiersin.org
Circulating tumor cells (CTCs) are cells spread from the primary tumor into the bloodstream
that might represent an important biomarker in lung cancer. The prognosis of patients …

Understanding the origin of CEMP–no stars through ultra-faint dwarfs

…, S Salvadori, Á Skúladóttir, I Vanni - Monthly Notices of the …, 2023 - academic.oup.com
The origin of Carbon Enhanced Metal-Poor (CEMP-no) stars with low abundances of
neutron-capture elements is still unclear. These stars are ubiquitous, found primarily in the Milky …

Understanding the checkpoint blockade in lung cancer immunotherapy

MG Dal Bello, A Alama, S Coco, I Vanni, F Grossi - Drug discovery today, 2017 - Elsevier
Highlights • The blockade of PD-1/PD-L1 and CTLA-4 has shown benefit in NSCLC. •
Clinical studies involving immune checkpoint inhibitors are ongoing in NSCLC. • Checkpoint …

[HTML][HTML] Non-BRAF mutant melanoma: molecular features and therapeutical implications

I Vanni, ET Tanda, B Dalmasso, L Pastorino… - Frontiers in Molecular …, 2020 - frontiersin.org
Melanoma is one of the most aggressive tumors of the skin, and its incidence is growing
worldwide. Historically considered a drug resistant disease, since 2011 the therapeutic …

Characterizing the true descendants of the first stars

I Vanni, S Salvadori, Á Skúladóttir… - Monthly Notices of …, 2023 - academic.oup.com
The metal-poor stars in the Galactic halo are thought to show the imprints of the first (Pop III)
stars, and thus provide a glance at the first episodes of star formation. In this work, we aim at …